switch from semaglutide to retatrutide Move over, Ozempic and Mounjaro. A new weight loss peptide is on the horizon—and it may be even better. Meet retatrutide, and find out what we know about it so far. Click RETATRUTIDE: A Medication for Diabetes

N Engl J Med 2020;382:21612.ArticlePubMed References The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin Fig

Reagent 2:Powder A and Solution B, can be stored at 28 temperature for 6 months

Key Takeaways: Wegovy vs Ozempic Both medications contain identical active ingredient: semaglutide Wegovy is FDA-approved for weight loss, Ozempic is approved for type 2 diabetes Wegovys maximum dose is 2.4 mg weekly, Ozempic tops out at 2 mg weekly Clinical trials showing 14.9% average weight loss used Wegovys 2.4 mg dose Wegovy costs $1,349/month, Ozempic costs $969/month (both without insurance) Insurance often covers Ozempic for diabetes but denies Wegovy for weight loss Compounded semaglutide at $199/month offers same benefits at fraction of the cost Both cause similar side effects: nausea, diarrhea, constipation The Basics: What Are Wegovy and Ozempic

Using Retatrutide During Cutting Cycles While much of this discussion has focused on bulking applications, Retatrutide truly excels during cutting phases

The earliest projected approval date is mid to late next year, assuming all ongoing trials complete successfully